With her doping suspension reduced to 15 months, from two years, Maria Sharapova and her legal team sounded triumphant on Tuesday.
But the truth is that nobody should be pumping a fist and bellowing, “Come on!” when it comes to the Sharapova case. None of the major players ended up winners.
Not the World Anti-Doping Agency, which botched the introduction of meldonium to its banned list this year, undermining faith in the system at a moment when faith is imperative.
Not Sharapova, who made errors in judgment and will still miss more than a year of competitive tennis and take a major financial hit for what the Court of Arbitration for Sport concluded on Tuesday was essentially an administrative oversight.